Clinical Trials on Cutaneous Malignant Melanoma
Total 7988 results
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Assistance Publique - Hôpitaux de ParisUnknownStage IV Melanoma | Stage III Melanoma | Amplification | Malignant Skin Melanoma T0France
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
Fudan UniversityRecruitingMalignant MelanomaChina
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
Regeneron PharmaceuticalsCompleted
-
Aarhus University HospitalCompletedMalignant MelanomaDenmark
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable FundsCompleted
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Unknown
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Inge Marie SvaneCopenhagen University Hospital at HerlevTerminated
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Scancell LtdTerminated
-
Hoffmann-La RocheCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Oslo University HospitalCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance
-
Uppsala UniversityUppsala University HospitalCompletedMalignant MelanomaSweden
-
Medivation, Inc.CompletedMelanoma | Malignant MelanomaUnited States, Israel
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
University Hospital TuebingenCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBioNumerik Pharmaceuticals, Inc.Terminated
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
MedImmune LLCCompletedMalignant MelanomaUnited States
-
SciBase ABCompleted
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Rigshospitalet, DenmarkCompleted
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Terminated
-
Gradalis, Inc.CompletedMelanoma | Malignant Melanoma | Melanoma RecurrentUnited States